Home > Diseases and Conditions > Optic neuritis

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

A.D.A.M. Medical Encyclopedia [Internet]. Atlanta (GA): A.D.A.M.; 2013.

A.D.A.M. Medical Encyclopedia.

Optic neuritis

Retro-bulbar neuritis

Last reviewed: September 16, 2011.

Optic neuritis is inflammation of the optic nerve. It may cause sudden, reduced vision in the affected eye.

Causes, incidence, and risk factors

The exact cause of optic neuritis is unknown.

The optic nerve carries visual informations from your eye to the brain. Sudden swelling of this nerve can damage the insulation (myelin sheath) surrounding each nerve fiber. This can result in permanent visual loss.

Conditions that have been linked with optic neuritis include:

Symptoms

  • Loss of vision in one eye over an hour or a few hours
  • Changes in the way the pupil reacts to bright light
  • Loss of color vision
  • Pain when you move the eye

Signs and tests

A complete medical examination can help rule out related diseases. Tests may include:

Treatment

Vision often returns to normal within 2 - 3 weeks with no treatment.

Corticosteroids given through a vein (IV) or taken by mouth may speed up recovery. Higher doses should be used cautiously, as they can have serious side effects.

Further tests may be needed to determine the cause of the neuritis. The condition causing the problem can then be treated.

Expectations (prognosis)

People who have optic neuritis without a disease such as multiple sclerosis have a good chance of recovery.

Optic neuritis caused by multiple sclerosis or other autoimmune diseases such as systemic lupus erythematosus has a poorer outlook. However, vision in the affected eye may still return to normal.

Complications

  • Body-wide side effects from corticosteroids
  • Vision loss

About 1 in 5 patients with a first episode of optic neuritis will develop myelin sheath inflammation elsewhere in the body, or will develop multiple sclerosis.

Calling your health care provider

Call your health care provider immediately if you have a sudden loss of vision in one eye, especially if you have eye pain.

If you have been diagnosed with optic neuritis, call your health care provider if:

  • Your vision decreases
  • The pain in the eye gets worse
  • Your symptoms do not improve with treatment

References

  1. Glaser JS. Topical diagnosis: prechiasmal visual pathways. In: Tasman W, Jaeger EA, eds. Duane’s Ophthalmology. 15th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2009:chap 5.
  2. Sra SK, Sra KK, Friedlaender M, Trocme SD. Immunology of neurologic and endocrine diseases that affect the eye. In: Tasman W, Jaeger EA, eds. Duane’s Ophthalmology. 15th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2009:chap 35.

Review Date: 9/16/2011.

Reviewed by: David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc., and Franklin W. Lusby, MD, Ophthalmologist, Lusby Vision Institute, La Jolla, California.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

Copyright © 2013, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

Copyright © 2013, A.D.A.M., Inc.

What works?

  • Corticosteroids for treating optic neuritisCorticosteroids for treating optic neuritis
    Optic neuritis is an inflammatory disease of the optic nerve characterized by sudden vision loss over several hours or days. The objective of this review was to assess the effectiveness of corticosteroids for acute optic neuritis. We included six randomized controlled trials (750 participants) conducted in Denmark, Germany, India, Japan, UK, and USA. These trials compared corticosteroid therapy to placebo or other treatment with variations in the route of administration and dose administered. At six months and one year, participants randomized to corticosteroids were more likely to have normal vision, contrast sensitivity (ability to distinguish fine changes in the shading of letters on an eye chart), and visual field (area visible when looking straight ahead) compared to participants receiving placebo, but these differences were not clinically meaningful. Adverse effects, although not consistently reported, included acne, high blood sugar, gastrointestinal problems, headache, fever, and sleep and mood disturbances. The findings suggest that there is no evidence of benefit with either oral or intravenous corticosteroids compared to placebo for the outcomes visual acuity, visual field, and contrast sensitivity.
See all (1) ...

Figures

  • External and internal eye anatomy.

In the news...

  • Image of womenNo proof found that depression is 'contagious'
    22 April 2013
    'Can you catch depression?', the Mail Online website asks on the strength of new US research into the concept of 'cognitive vulnerability'. Cognitive vulnerability is where unhelpful patterns of thin...
more...

MedlinePlus.gov links to free, reliable, up-to-date health information from the National Institutes of Health (NIH) and other trusted health organizations.

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk